Erythromycin is an antibiotic used for the treatment of a number of bacterial infections. This includes respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis
A Anant Labs fabrica e fornece impurezas de Erythromycin de alta qualidade para o mercado global. Nossas impurezas EP de Erythromycin são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
erythromycin114-07-8Erythromycin AE-MycinAbomacetinIlotycinEmgelErymaxEritromicinaErythromycineErythromycinumRobimycinTorlamicinaErydermErythromycin baseErycetteErythrogranErygelSansacErythro-StatinErythra-DermAkne-MycinERYCE-GladesEry-TabE-BaseErythroguentDotycinStiemycinR-P MycinEryc SprinklesE-Solve 2Erythromast 36T-StatC-Solve-2Eryc 125erythromycin-AOftalmolosa Cusi EritromicinaStaticinRetcinDTXSID4022991J01FA01NSC-55929PCE (ERYTHROMYCIN)63937KV33DDTXCID102991CHEBI:42355NSC55929(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione7540-22-9KerymaxSpotexErymax sprinkleAknemycin plusTStatEryacne 2Eryacne 4Gallimycin-36T Stat(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-((2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl)oxy-14-ethyl-7,12,13-trihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dioneErythro 200Lactate, ErythromycinRommix 250 ecRommix 500 ecPhosphate, ErythromycinRefChem:6427Erythro-100 InjectionAPI E.M. ErythromycinErythromycin Base FilmtabErythro-36, Erythro-DryAPI E.M ERYTHROMYCINCHEBI:48923erythromycin topical solution 2%Gallimycin Injection, Gallimycin-100(2R,3S,4S,5R,6R,8R,10R,11R,12S,13R)-5-(3,4,6-Trideoxy-3-dimethylamino-beta-D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethyl-9-oxopentadecan-13-olide204-040-1616-217-43''-O-DemethylerythromycinRP-MycinEryacneErythrocinPantomicinaMFCD00084654A/T/SerythroErmycinErycenAkninTheramycin ZAk-MycinErytabIndermBenzamycinCHEMBL532DumotrycinMephamycinWemid(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dioneErythromycin C-13EndoeritrinEritomicinaErythrodermErytrociclinPharyngocinProterytrinAcneryneAcnesolAknemycinC37H67NO13DerimerDeripilErisoneEryacnenErydermerEryhexalErysafeIloticinaLatotrydLederpaxMercinaOftamoletsPantodermPantodrinRomycinStiemicynTiprocinEmuvinEmycinErecinErymedErytopAustriaSErosEry-maxinErythro-TevaSans-acneErimycin-TEry-DiolanInderm GelDel-MycinAknederm Ery GelUdima Ery Gelcyclotetradecane-2,10-dioneEmu-Ve8HPH7ND0LNSkid Gel E(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dioneAkne Cordes LosungERYIlosone (estolate)Ilotycin T.S.E-Mycin (base)Ery-Tab (base)Emu-VEry-BE-Base (base)ERYC (base)N-Methylerythromycin APCE Dispertab (base)Eryc-125Eryc-250Eritromicina [INN-Spanish]Erythromycine [INN-French]Erythromycinum [INN-Latin]Erythromycin, labeled with carbon-13Staticin (TN)(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dioneAkne-mycin (TN)Erygel (TN)Eryc (TN)T-stat (TN)Pce (TN)SR-05000001618Sentry AQ mardel maracynErythromycin & VRC3375erthromycintrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxaCCRIS 9078Erythromycin RS82343-12-2UNII-63937KV33DHSDB 3074NCGC00094670-01Erythromycin [USP:INN:BAN:JAN](3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethylte(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dioneCAS-114-07-8Prestwick_205EINECS 204-040-1Erythromycin A CRSNSC 55929215031-94-0Spectrum_000115Spectrum_000659Erythromycin (Standard)AI3-50138EM-APrestwick3_000151Spectrum2_000759Spectrum2_001263Spectrum4_000538Spectrum5_001596UNII-8HPH7ND0LNERYTHROMYCIN [MI]E0751ERYTHROMYCIN [INN]ERYTHROMYCIN [JAN]EC 204-040-1ERYTHROMYCIN [HSDB]SCHEMBL2601ERYTHROMYCIN [VANDF]BSPBio_000282BSPBio_002480ERYTHROMYCIN [MART.]KBioGR_001175KBioSS_000555KBioSS_001139MLS001066618BIDD:GT0017DivK1c_000294DivK1c_000397DivK1c_000702ERYTHROMYCIN [USP-RS]ERYTHROMYCIN [WHO-DD]ERYTHROMYCIN [WHO-IP]SPECTRUM1500280SPBio_000778SPBio_001226Erythromycin (mixture A,B,C)BPBio1_000312GTPL1456orb1309999orb3025580Erythromycin (JP18/USP/INN)HMS500O16KBio1_000294KBio1_000397KBio1_000702KBio2_000555KBio2_001139KBio2_003123KBio2_003707KBio2_005691KBio2_006275ERYTHROMYCIN [GREEN BOOK]MSK7801NINDS_000294NINDS_000397NINDS_000702ERYTHROMYCIN [ORANGE BOOK]HMS1920M04HMS2091D05HMS2095O04HMS3712O04Pharmakon1600-01500280ERYTHROMYCIN [EP MONOGRAPH]HY-B0220RKL10096ERYTHROMYCIN [USP MONOGRAPH]Tox21_111311Tox21_111869Tox21_300515BDBM50344942CCG-38992LMPK04000006MSK7801-100AMSK7801-100MNSC756759ERYTHROMYCINUM [WHO-IP LATIN]AKOS015895249MSK7801-1000AMSK7801-1000MAE22796DB00199Erythromycin for system suitability CRSNSC-756759BENZAMYCIN COMPONENT ERYTHROMYCINIDI1_000294IDI1_000397IDI1_000702SMP1_000119NCGC00179619-01NCGC00179619-02NCGC00179619-03NCGC00179619-18NCGC00254234-01AC-12744AC-12901SMR000544946SY070227Erythromycin for microbiological assay CRSErythromycin, potency: >=850 mug per mgErythromycin, tested according to Ph.Eur.SBI-0051368.P003Erythromycin, N-demethyl-N-(methyl-11C)-E6994Erythromycin 1000 microg/mL in AcetonitrileErythromycin Solution in Methanol, 100ug/mLNS00000203Third international Standard for ErythromycinErythromycin for impurity M identification CRSErythromycin Solution in Methanol, 1000ug/mLErythromycin, meets USP testing specificationsC01912D00140E-3250AB00051981_09AB00051981_10Erythromycin Solution in Acetonitrile, 100ug/mLErythromycin, Biotechnology Performance CertifiedErythromycin estolate impurity, free erythromycin-Erythromycin Solution in Acetonitrile, 1000ug/mLQ213511SR-01000799155Erythromycin, Antibiotic for Culture Media Use OnlyErythromycin, BioReagent, suitable for cell cultureSR-01000799155-2SR-05000001618-1SR-05000001618-2BRD-K63550407-001-12-7BRD-K63550407-001-13-5BRD-K63550407-028-03-9BRD-K63550407-028-04-7Z2587996953Erythromycin (mixture of A,B,C) 100 |Ig/mL in AcetonitrileErythromycin A, European Pharmacopoeia (EP) Reference StandardRoxithromycin EP Impurity A; Erythromycin;Erythromycin A(USP)Erythromycin, United States Pharmacopeia (USP) Reference StandardERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN [EP IMPURITY]ERYTHROMYCIN ESTOLATE IMPURITY, FREE ERYTHROMYCIN- [USP IMPURITY]Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference StandardErythromycin, Pharmaceutical Secondary Standard; Certified Reference Material(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)[3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-|A-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-|A-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dioneErythromycin A; Dotycin; Erycin; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
